Prime Medicine | 4:持股變動聲明-董事 Marrazzo Jeffrey D
Prime Medicine | 3:首次持股聲明- GV 2023 GP, L.L.C.
Prime Medicine | SC 13G/A:超過5%持股股東披露文件(修正)-Alphabet Holdings LLC(12.2%),XXVI Holdings Inc.(12.2%)等
Prime Medicine | 4:持股變動聲明-高管 Gottesdiener Keith Michael
Prime Medicine | 4:持股變動聲明-高管 Goldwasser Meredith
Prime Medicine | 4:持股變動聲明-高管 LEE ANN L.
Prime Medicine | 4:持股變動聲明-高管 Duffield Jeremy
Prime Medicine | 4:持股變動聲明-高管 Brudnick Richard
Prime Medicine | 4:持股變動聲明-高管 Alenson Carman
Prime Medicine | SC 13D:超過5%持股股東披露文件-ARCH Venture Fund X, L.P.(12.9%),ARCH Venture Fund X Overage, L.P.(12.9%)等
Prime Medicine | 4:持股變動聲明-董事 NELSEN ROBERT
Prime Medicine | 4:持股變動聲明-股東 ARCH Venture Partners XII, LLC
Prime Medicine | 4:持股變動聲明-股東 ARCH Venture Partners X, LLC
Prime Medicine | SC 13G/A:超過5%持股股東披露文件(修正)-Alphabet Holdings LLC(12.2%),XXVI Holdings Inc.(12.2%)等
Prime Medicine | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(9.338%),Abigail P. Johnson(9.338%)
Prime Medicine | 3:首次持股聲明-高管 Reine Allan
Prime Medicine | 4:持股變動聲明-高管 Reine Allan
Prime Medicine | 4:持股變動聲明-高管 Gottesdiener Keith Michael
Prime Medicine | 4/A:持股變動聲明(修正)-股東 Liu David R.
Prime Medicine | 4:持股變動聲明-股東 Liu David R.
暫無數據